Gemini Laboratories

Gemini Laboratories, part of Amneal Pharmaceuticals, is dedicated to challenging conventions to make healthy possible through their comprehensive portfolio of approximately 280 generic and specialty pharmaceuticals. The company emphasizes innovation in areas such as oncology and Parkinson's disease, striving to increase access to life-saving medications like Naloxone and enhancing patient care.

With a strong commitment to research and development, Gemini Laboratories is at the forefront of creating essential medicines, including first-to-file and first-to-market complex therapies. Their culture is built on inspiring actions that encourage their team to rise, lead, and succeed for the benefit of patients and their families.

Generated from the website